MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 - Germany

This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example MedicationRequest: MedicationRequest - Oxaliplatin (abgebrochen wegen Neuropathie)

English

Profile: MII PR Onkologie Therapieempfehlung Medikation version: 2027.0.0-ballot.1

status: Stopped

statusReason: Oxaliplatin discontinued after cycle 6 due to grade 3 peripheral neuropathy (CTCAE). Patient continued with 5-FU + Leucovorin only for remaining 6 cycles.

intent: Proposal

medication: Oxaliplatin

subject: Martin Beispiel Male, DoB: 1958-11-03

authoredOn: 2024-03-05

reasonReference: Condition Bösartige Neubildung: Colon ascendens

note:

Administered for cycles 1-6 only. Stopped due to cumulative neurotoxicity.